| Hang Seng China Enterprises | 91.720 HKD | +0.120 | +0.131% | 4.91M | 450.10M | 91.592 (+0.140%) HKD as at 2025/09/04 | | |
| Hang Seng Index | 25.700 HKD | +0.080 | +0.312% | 16.16M | 415.50M | 25.639 (+0.237%) HKD as at 2025/09/04 | | |
| Hang Seng TECH Index | 5.505 HKD | +0.020 | +0.365% | 74.68M | 410.58M | 5.479 (+0.480%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.595 HKD | +0.050 | +0.902% | 16.40M | 91.48M | 5.542 (+0.962%) HKD as at 2025/09/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.494 HKD | -0.014 | -0.928% | 32.10M | 48.08M | 1.512 (-1.204%) HKD as at 2025/09/04 | | |
| Hang Seng TECH Index | 5.600 HKD | +0.030 | +0.539% | 5.94M | 33.21M | 5.564 (+0.642%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.735 HKD | +0.035 | +0.614% | 5.63M | 32.28M | 5.691 (+0.771%) HKD as at 2025/09/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.984 HKD | -0.008 | -0.402% | 15.89M | 31.48M | 1.998 (-0.716%) HKD as at 2025/09/04 | | |
| Hang Seng China Enterprises | 10.600 HKD | +0.020 | +0.189% | 787.00K | 8.34M | 10.614 (-0.128%) HKD as at 2025/09/03 | | |
| CSI 300 | 49.260 HKD | +0.200 | +0.408% | 163.60K | 8.06M | 50.407 (-2.275%) HKD as at 2025/09/03 | | |
| Hang Seng TECH Index | 11.820 HKD | +0.050 | +0.425% | 608.20K | 7.18M | 11.980 (-1.337%) HKD as at 2025/09/03 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 6.255 HKD | +0.195 | +3.218% | 982.30K | 6.09M | 6.148 (+1.739%) HKD as at 2025/09/04 | | |
| FTSE China A50 | 14.500 HKD | +0.040 | +0.277% | 379.00K | 5.49M | 14.549 (-0.340%) HKD as at 2025/09/04 | | |
| FTSE China A50 | 15.570 HKD | +0.040 | +0.258% | 343.80K | 5.35M | 15.826 (-1.618%) HKD as at 2025/09/03 | | |
| FTSE US Treasury 20+ Years Index | 68.380 HKD | +0.520 | +0.766% | 63.61K | 4.35M | 67.799 (+0.857%) HKD as at 2025/09/03 | | |
| Hang Seng High Dividend Yield | 29.680 HKD | +0.160 | +0.542% | 91.20K | 2.71M | 29.851 (-0.572%) HKD as at 2025/09/03 | | |
| FactSet China Robotics and Artificial Intelligence Index (net total return) | 54.020 HKD | +0.220 | +0.409% | 50.15K | 2.70M | 55.974 (-3.491%) HKD as at 2025/09/03 | | |
| SSE Science and Technology Innovation Board 50 Index | 11.270 HKD | +0.010 | +0.089% | 231.50K | 2.62M | 11.319 (-0.429%) HKD as at 2025/09/04 | | |
| FactSet China Semiconductor Index (net total return) | 49.800 HKD | -0.200 | -0.400% | 50.40K | 2.50M | 53.383 (-6.711%) HKD as at 2025/09/03 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.698 HKD | -0.074 | -1.962% | 673.30K | 2.49M | 3.789 (-2.407%) HKD as at 2025/09/03 | | |
| CSI 300 | 45.040 CNY | +0.140 | +0.312% | 47.00K | 2.12M | 46.144 (-2.393%) CNY as at 2025/09/03 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 17.400 HKD | +0.150 | +0.870% | 121.60K | 2.12M | 17.352 (+0.274%) HKD as at 2025/09/04 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.310 HKD | -0.120 | -1.151% | 159.10K | 1.64M | 10.409 (-0.947%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.408 HKD | +0.042 | +0.962% | 317.30K | 1.40M | 4.446 (-0.844%) HKD as at 2025/09/04 | | |
| London Gold Fixing Price | 2,554.000 HKD | +9.000 | +0.354% | 505.00 | 1.29M | N/A | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 13.680 HKD | +0.080 | +0.588% | 87.30K | 1.20M | 13.635 (+0.334%) HKD as at 2025/09/04 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 13.610 HKD | +0.070 | +0.517% | 63.60K | 865.52K | 13.553 (+0.424%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 18.960 HKD | +0.130 | +0.690% | 44.10K | 835.57K | 19.227 (-1.389%) HKD as at 2025/09/03 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.420 HKD | -0.090 | -0.856% | 70.10K | 729.95K | 10.512 (-0.872%) HKD as at 2025/09/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 46.280 HKD | -0.760 | -1.616% | 15.55K | 722.32K | 46.941 (-1.408%) HKD as at 2025/09/04 | | |